Onbehandelde patiënten
WAVELINE-011 (MK-2140-011)
A Randomized, Open-label, Multicenter, Phase 2 Study Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vdotin Plus R-CHP) in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL)
- Principal investigator: Prof. Dr. Vibeke Vergote
- More information: NCT06890884
- Internal reference number: S70142
SOUNDTRACK-D2
A Phase III, Multicentre, Open-label, Randomised Study Evaluating the Efficacy and Safety of R-mini-CHOP × 2 followed by AZD0486 versus R-mini-CHOP × 6 in Elderly or Unfit Participants with Newly Diagnosed Large B-cell Lymphoma
- Principal investigator: Prof. Dr. Vibeke Vergote
- More information: NCT07215585
- Internal reference number: S71083
Behandelde patiënten
Momenteel geen actieve studies.
Vragen en contact
-
Via deze weg kunt u geen afspraak maken.